Financial Counselors Inc’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,233
Closed -$248K 536
2021
Q1
$248K Sell
2,233
-780
-26% -$96.5K 0.01% 479
2020
Q4
$358K Buy
3,013
+170
+6% +$18.3K 0.01% 405
2020
Q3
$248K Buy
+2,843
New +$248K 0.01% 435
2020
Q2
Sell
-2,195
Closed -$219K 528
2020
Q1
$219K Buy
2,195
+250
+13% +$27.1K 0.01% 415
2019
Q4
$223K Buy
1,945
+240
+14% +$29K 0.01% 496
2019
Q3
$215K Sell
1,705
-140
-8% -$17.8K 0.01% 494
2019
Q2
$222K Sell
1,845
-480
-21% -$47.2K 0.01% 471
2019
Q1
$203K Buy
+2,325
New +$211K 0.01% 494

Other funds holding HAE

Financial Counselors Inc's HAE Position: Q2 2021 in Review

Financial Counselors Inc sold out of Haemonetics (HAE) in Q2 2021, closing a stake of 2,233 shares — an estimated $248K sold.

Financial Counselors Inc first reported a position in HAE in Q1 2019 and held it in 8 quarters. The position peaked at $358K in Q4 2020. 258 funds tracked by Wall St. Rank hold HAE as of Q2 2021.

  • Financial Counselors Inc reported no remaining Haemonetics position as of Q2 2021 after selling out during the quarter.
  • Financial Counselors Inc sold 2,233 Haemonetics shares in Q2 2021, an estimated $248K.
  • Financial Counselors Inc first reported a position in Haemonetics in Q1 2019 and held it in 8 quarters.
  • Financial Counselors Inc's Haemonetics position peaked at $358K in Q4 2020.
  • 258 funds tracked by Wall St. Rank held Haemonetics as of Q2 2021.

Based on Financial Counselors Inc's 13F filing for Q2 2021, filed 3 Aug 2021.